SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of BioInsight, a new business within Illumina, developed to meet industry demand for deeper biologic ...
The company shared pilot data about its Constellation tech and released 5-Base, a product for jointly analyzing genetic and epigenetic data.
Plasmidsaurus, the leading global Sequencing as a Service company, today announced the launch of its new RNA-Seq service.
Unlike conventional methylation conversion technologies, Illumina's proprietary conversion chemistry selectively converts methylated cytosine to thymine. This selective conversion of methylated ...
Overall growth in revenues, capital, and activity among leading companies reflect the field’s increasing importance as highlighted in this year’s Top 10 Spatial Biology Companies of 2025. The below Up ...
The Broad Institute gene-sequencing lab used Roche equipment to read infants’ DNA genomes in less than four hours, cutting an ...
Illumina is launching a new informatics and artificial intelligence software business aimed at drug developers, with the goal of digesting large-scale DNA sequencing and multi-omics data. The ...
Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...
PACB, popularly known as PacBio, announced innovations to its Revio and Vega platforms last week. The innovations are expected to lower sequencing costs, add new multiomic capabilities and expand ...
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx .
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback